MONTREAL, CANADA--(Marketwire - March 27, 2008) - ART Advanced Research Technologies Inc. (ART) (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today announces its financial results for the fourth quarter and year ended December 31, 2007. Revenues for the fourth quarter of 2007 increased by 120% to $1,384,014, compared to $628,907 for the same quarter of 2006. Revenues for the year ended December 31, 2007 were $2,087,920, compared to $3,081,776 for the year ended December 31, 2006. For the 2007 fourth quarter, the loss before financial expenses, gain on disposal of an investment and income taxes (operating loss) decreased by $1,000,186, or 37%, to $1,706,286 from $2,706,472 for the same period a year ago.
